Zepeda v. Wexford Health Sources, Inc.

CourtDistrict Court, S.D. Illinois
DecidedJanuary 29, 2025
Docket3:24-cv-02455
StatusUnknown

This text of Zepeda v. Wexford Health Sources, Inc. (Zepeda v. Wexford Health Sources, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Zepeda v. Wexford Health Sources, Inc., (S.D. Ill. 2025).

Opinion

THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF ILLINOIS

FRANCISCO ZEPEDA,

Plaintiff,

v. Case No. 3:24-cv-02455-GCS

WEXFORD HEALTH SOURCES, INC., ROB JEFFREYS, LATOYA HUGHES, DEBBIE KNAUER, DAVID MITCHELL, M. LIVELY, CHRISTINE BROWN, BOB BLUM, and DR. PERCY MYERS,

Defendants.

MEMORANDUM & ORDER SISON, Magistrate Judge: Plaintiff Francisco Zepeda, an inmate of the Illinois Department of Corrections (“IDOC”) who is currently incarcerated at Centralia Correctional Center, brings this action pursuant to 42 U.S.C. § 1983 for deprivations of his constitutional rights while at Pinckneyville Correctional Center. In the Complaint, Zepeda alleges he was delayed and denied medications for his medical conditions in violation of the Eighth Amendment. This case is now before the Court for preliminary review of the Complaint pursuant to 28 U.S.C. § 1915A.1 Under Section 1915A, the Court is required to screen prisoner complaints to filter out non-meritorious claims. See 28 U.S.C. § 1915A(a). Any

1 The Court has jurisdiction to screen the Complaint due to Plaintiff’s consent to the full jurisdiction of a Magistrate Judge (Doc. 6), and the limited consent to the exercise of Magistrate Judge jurisdiction by the IDOC and Wexford Health Sources, Inc. as set forth in the Memoranda of Understanding between the Court and these two entities. portion of a complaint that is legally frivolous, malicious, fails to state a claim upon which relief may be granted, or asks for money damages from a defendant who by law is

immune from such relief must be dismissed. See 28 U.S.C. § 1915A(b). THE COMPLAINT Zepeda alleges that he suffers from hypertension, atrial fibrillation (“AFib”), congestive heart failure, and sleep apnea. (Doc. 1, p. 4). He is prescribed several medications including Losartan, Hydralazine, Carvedilol, Imdur, Aspirin, Cardizem/Diltiazem, Lasix, Potassium, and Clonidine. Id. Some of his medications were

labeled “keep on person” (“KOP”) meaning he carried the medication with him and took as directed. But the medications were taken from him because healthcare staff did not believe he was taking the medications properly. On June 21, 2022, he wrote a grievance indicating that on June 9, 2022, his blood pressure was 161/117, and he was not able to receive medications, including Lasix, Losartan, Carvedilol, and Potassium, from the

medline nurse. Id. Because his medications were taken away, he was now on direct observation therapy (“DOT”) meaning that he had to receive the medications directly from the nurse. Id. From June 18 through June 21, Zepeda also went without his Cardizem prescription for AFib because the nurse did not have the medication at medline. Id. Zepeda alleges that he was denied access to his mediations because there is a

policy or practice of prescribing non-narcotic medications as DOT rather than KOP (Doc. 1, p. 5). Zepeda alleges that DOT poses additional risks because he does not receive his medication in a timely fashion due to the time that nurses hand out medications, which can vary from day to day. Id. Zepeda made several requests to Christine Brown and Dr. Myers for his prescribed medications, but they did not believe that he lacked his medication. Id. On July 26, 2022, Administrative Review Board (“ARB”) members Debbie

Knauer and Rob Jeffreys signed off on the grievance, noting that Warden David Mitchell was to ensure that all medications were administered correctly. Id. On September 14, 2022, Zepeda submitted another grievance arguing that the DOT policy was affecting his health due to medication errors and the failure to monitor his blood pressure. (Doc. 1, p. 5). M. Lively denied his grievance without investigating his claims. Id. On May 10, 2023, Zepeda submitted another grievance about medication errors

associated with his KOP medications. Id. Zepeda noted that when he turned in his KOP medications with doses left in the pack, the doses were not accurately documented. Lively and Knauer denied the grievance. Id. On April 15, 2023, Zepeda submitted a grievance complaining that he went without his Losartan medication from March 15 through April 12. (Doc. 1, p. 6). He

submitted several requests for refills to Brown and Dr. Myers. Id. His requests were ignored. He did not receive his medication until nurse sick call on April 14, 2023. Id. His grievance was denied. On May 21, 2023, Zepeda submitted another grievance because he went without his Losartan from April 26 through May 17. He again made requests for refills to Brown

and Dr. Myers to no avail. (Doc. 1, p. 6). On May 17, 2023, Physician Assistant (“PA”) Desai refilled his medication. His grievance was again denied. On October 2, 2023, he submitted a grievance about going without his heart medication Diltiazem from September 28 through October 26. Id. He, again, made several requests to Brown and Dr. Myers for refills but was ignored. Id. On October 26, 2023, he met with NP Bob Blum and his blood pressure was 168/120. Id. He informed Blum about his requests and grievance.

Zepeda asked Blum if the healthcare unit had been informed of his grievance. Id. Blum responded that Zepeda could “catch more flies with sugar” and then placed Zepeda on DOT. Zepeda explained the risks of DOT and his issues with medlines in the past, but Blum still required Zepeda to receive his medication DOT. Id. His grievance was denied. In response to a subsequent grievance about missing medications, Christine Brown responded that Zepeda had not received his Diltiazem since September but that she had

the pharmacy place an order that day. Id. at p. 7. The ARB denied his grievance, and Latoya Hughes signed off on the denial. Id. On June 23, 2024, Zepeda submitted another grievance over his concerns of receiving his medication DOT and argued that his medication should be labeled KOP. (Doc. 1, p. 7). Zepeda alleges that most of his blood pressure medications at that point

were KOP except for his Hydralazine. Id. In response, Brown indicated that the medication was switched to DOT because he was refusing to come to medline. Zepeda maintains that her response was a lie. Id. His grievance was denied. PRELIMINARY DISMISSALS

To the extent Zepeda seeks to bring a claim against the Illinois Department of Corrections, he fails to state a claim. Zepeda cannot maintain a claim against IDOC because it is not a “person” amendable to suit under Section 1983. See, e.g., Will v. Michigan Dept. of State Police, 491 U.S. 58, 71 (1989) (stating that “neither a State nor its officials acting in their official capacities are ‘persons’ under [Section] 1983”). Any claim against the IDOC is, thus, DISMISSED with prejudice.

Zepeda also alleges that numerous officials denied his grievances or failed to properly investigate the grievances regarding his medical care. He alleges that Defendants M. Lively, Debbie Knauer, Rob Jeffreys, and LaToya Hughes failed to investigate Zepeda’s claims and correct the issues he experienced in response to his grievances. But their simple denial or mishandling of a grievance fails to state a claim. See Owens v. Hinsley, 635 F.3d 950, 953 (7th Cir. 2011); Grieveson v. Anderson, 538 F.3d 763, 772

n.3 (7th Cir. 2008).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Will v. Michigan Department of State Police
491 U.S. 58 (Supreme Court, 1989)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Owens v. Hinsley
635 F.3d 950 (Seventh Circuit, 2011)
Gomez v. Randle
680 F.3d 859 (Seventh Circuit, 2012)
Grieveson v. Anderson
538 F.3d 763 (Seventh Circuit, 2008)
Kevin Dixon v. Cook County, Illinois
819 F.3d 343 (Seventh Circuit, 2016)
Jocelyn Chatham v. Randy Davis
839 F.3d 679 (Seventh Circuit, 2016)
Larry Howell v. Wexford Health Sources, Inc.
987 F.3d 647 (Seventh Circuit, 2021)
Spiegel v. McClintic
916 F.3d 611 (Seventh Circuit, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Zepeda v. Wexford Health Sources, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/zepeda-v-wexford-health-sources-inc-ilsd-2025.